- Joined
- Aug 1, 2017
- Messages
- 69
Most bodybuilders and serious athletes will have some degree of LVH. As heart disease runs in my family I have looked in to reversing/preventing LVH. The good news is there are a number of things that help, I wanted to share the top five as far as I can tell:
1) L-carnitine
https://www.ncbi.nlm.nih.gov/pubmed/18503218
Supplementation with L-carnitine induced regression of LVH in patients on hemodialysis, even for those with normal systolic function.
2) CoQ
https://www.ncbi.nlm.nih.gov/pubmed/9266516
All patients noted improvement in symptoms of fatigue and dyspnea with no side effects noted. The mean interventricular septal thickness improved significantly
3) Taurine
https://www.researchgate.net/public...hypertrophy_in_renovascular_hypertensive_rats
Taurine which effectively suppress myocardial cell hypertrophy and collagenous fiber productive reaction by decreasing myocardial local RAAS and c-fos mRNA expression can produce good preventive effect on left ventricle hypertrophy caused by renal hypertension.
4) Testosterone
https://www.ncbi.nlm.nih.gov/pubmed/14713281
The results of the present study are consistent with the hypothesis that lower levels of testosterone in men are associated with higher blood pressure, left ventricular mass, and left ventricular hypertrophy.
5) Vitamin D
https://www.ncbi.nlm.nih.gov/pubmed/15882312
Recent studies using vitamin D receptor deficient mice as a model demonstrate a crucial role of vitamin D in regulation of the renin-angiotensin system. Additionally, there is emerging evidence linking treatment with vitamin D to improved survival on hemodialysis and improvement in cardiac function. The emergence of this data is focusing attention on the previously underappreciated nonmineral homeostatic effects of vitamin D that very likely play an important role in the pathogenesis of cardiac disease in ESRD.
https://www.ncbi.nlm.nih.gov/pubmed/21937207
In the absence of major cardiovascular risk factors, 25(OH)D deficiency is a frequent finding in EH patients and is independently associated with LVH.
Honorable mention) Possibly fish oil:
https://www.ncbi.nlm.nih.gov/pubmed/18360184
In summary, any patient with documented coronary heart disease and those with risk factors for sudden cardiac death, such as left ventricular dysfunction, left ventricular hypertrophy, prior myocardial infarction, or high-grade ventricular dysrhythmias, should consider fish oil supplementation.
1) L-carnitine
https://www.ncbi.nlm.nih.gov/pubmed/18503218
Supplementation with L-carnitine induced regression of LVH in patients on hemodialysis, even for those with normal systolic function.
2) CoQ
https://www.ncbi.nlm.nih.gov/pubmed/9266516
All patients noted improvement in symptoms of fatigue and dyspnea with no side effects noted. The mean interventricular septal thickness improved significantly
3) Taurine
https://www.researchgate.net/public...hypertrophy_in_renovascular_hypertensive_rats
Taurine which effectively suppress myocardial cell hypertrophy and collagenous fiber productive reaction by decreasing myocardial local RAAS and c-fos mRNA expression can produce good preventive effect on left ventricle hypertrophy caused by renal hypertension.
4) Testosterone
https://www.ncbi.nlm.nih.gov/pubmed/14713281
The results of the present study are consistent with the hypothesis that lower levels of testosterone in men are associated with higher blood pressure, left ventricular mass, and left ventricular hypertrophy.
5) Vitamin D
https://www.ncbi.nlm.nih.gov/pubmed/15882312
Recent studies using vitamin D receptor deficient mice as a model demonstrate a crucial role of vitamin D in regulation of the renin-angiotensin system. Additionally, there is emerging evidence linking treatment with vitamin D to improved survival on hemodialysis and improvement in cardiac function. The emergence of this data is focusing attention on the previously underappreciated nonmineral homeostatic effects of vitamin D that very likely play an important role in the pathogenesis of cardiac disease in ESRD.
https://www.ncbi.nlm.nih.gov/pubmed/21937207
In the absence of major cardiovascular risk factors, 25(OH)D deficiency is a frequent finding in EH patients and is independently associated with LVH.
Honorable mention) Possibly fish oil:
https://www.ncbi.nlm.nih.gov/pubmed/18360184
In summary, any patient with documented coronary heart disease and those with risk factors for sudden cardiac death, such as left ventricular dysfunction, left ventricular hypertrophy, prior myocardial infarction, or high-grade ventricular dysrhythmias, should consider fish oil supplementation.